<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Kiichi Y</submitter><funding>the Research Promotion Program for Acquiring KAKENHI, Ritsumeikan University</funding><funding>Japan Society for the Promotion of Science</funding><pagination>1389</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10976149</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>29(6)</volume><pubmed_abstract>Makaluvamine J, a pyrroloiminoquinone alkaloid of marine sponge origin, and its analogs were synthesized and assessed for their potential to develop as a novel and selective growth inhibitor targeting human pancreatic cancer PANC-1 cells. Ts-damirone B, a common precursor featuring a pyrroloiminoquinone core structure, was synthesized through Bartoli indole synthesis and IBX-mediated oxidation. Late-stage diversification at &lt;i>N&lt;/i>-5 and &lt;i>N&lt;/i>-9 yielded makaluvamine J and several analogs. A structure-activity relationship (SAR) analysis highlighted the significance of the lipophilic side chain at &lt;i>N&lt;/i>-9 for the growth inhibitory activity of PANC-1 cells. The modest alkyl group at &lt;i>N&lt;/i>-5 was found to improve selectivity against other cancer cells. Among the prepared analogs, the tryptamine analog &lt;b>24&lt;/b> showed potent and selective cytotoxicity (IC&lt;sub>50&lt;/sub> = 0.029 µM, selective index = 13.1), exceeding those of natural products.</pubmed_abstract><journal>Molecules (Basel, Switzerland)</journal><pubmed_title>Unified Synthesis and Biological Evaluation of Makaluvamine J and Its Analogs.</pubmed_title><pmcid>PMC10976149</pmcid><funding_grant_id>22K05339</funding_grant_id><funding_grant_id>B21-0051</funding_grant_id><pubmed_authors>Ishino K</pubmed_authors><pubmed_authors>Kiichi Y</pubmed_authors><pubmed_authors>Fukuoka K</pubmed_authors><pubmed_authors>Kotoku N</pubmed_authors><pubmed_authors>Kitano A</pubmed_authors></additional><is_claimable>false</is_claimable><name>Unified Synthesis and Biological Evaluation of Makaluvamine J and Its Analogs.</name><description>Makaluvamine J, a pyrroloiminoquinone alkaloid of marine sponge origin, and its analogs were synthesized and assessed for their potential to develop as a novel and selective growth inhibitor targeting human pancreatic cancer PANC-1 cells. Ts-damirone B, a common precursor featuring a pyrroloiminoquinone core structure, was synthesized through Bartoli indole synthesis and IBX-mediated oxidation. Late-stage diversification at &lt;i>N&lt;/i>-5 and &lt;i>N&lt;/i>-9 yielded makaluvamine J and several analogs. A structure-activity relationship (SAR) analysis highlighted the significance of the lipophilic side chain at &lt;i>N&lt;/i>-9 for the growth inhibitory activity of PANC-1 cells. The modest alkyl group at &lt;i>N&lt;/i>-5 was found to improve selectivity against other cancer cells. Among the prepared analogs, the tryptamine analog &lt;b>24&lt;/b> showed potent and selective cytotoxicity (IC&lt;sub>50&lt;/sub> = 0.029 µM, selective index = 13.1), exceeding those of natural products.</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Mar</publication><modification>2025-04-26T11:31:20.846Z</modification><creation>2025-04-06T13:41:02.731Z</creation></dates><accession>S-EPMC10976149</accession><cross_references><pubmed>38543025</pubmed><doi>10.3390/molecules29061389</doi></cross_references></HashMap>